HomeCompareFCHPX vs JNJ

FCHPX vs JNJ: Dividend Comparison 2026

FCHPX yields 19.82% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FCHPX wins by $52.2K in total portfolio value
10 years
FCHPX
FCHPX
● Live price
19.82%
Share price
$10.09
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$72.2K
Annual income
$6,611.57
Full FCHPX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — FCHPX vs JNJ

📍 FCHPX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFCHPXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FCHPX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FCHPX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FCHPX
Annual income on $10K today (after 15% tax)
$1,684.84/yr
After 10yr DRIP, annual income (after tax)
$5,619.83/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, FCHPX beats the other by $4,916.22/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FCHPX + JNJ for your $10,000?

FCHPX: 50%JNJ: 50%
100% JNJ50/50100% FCHPX
Portfolio after 10yr
$46.1K
Annual income
$3,719.68/yr
Blended yield
8.06%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

FCHPX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FCHPX buys
0
JNJ buys
0
No recent congressional trades found for FCHPX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFCHPXJNJ
Forward yield19.82%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$72.2K$20.0K
Annual income after 10y$6,611.57$827.78
Total dividends collected$40.9K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FCHPX vs JNJ ($10,000, DRIP)

YearFCHPX PortfolioFCHPX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$12,682$1,982.16$10,676$355.77+$2.0KFCHPX
2$15,919$2,349.35$11,407$389.39+$4.5KFCHPX
3$19,790$2,756.10$12,198$426.53+$7.6KFCHPX
4$24,377$3,202.04$13,056$467.62+$11.3KFCHPX
5$29,770$3,686.25$13,987$513.12+$15.8KFCHPX
6$36,061$4,207.21$14,998$563.56+$21.1KFCHPX
7$43,348$4,762.89$16,098$619.52+$27.3KFCHPX
8$51,733$5,350.82$17,295$681.69+$34.4KFCHPX
9$61,323$5,968.11$18,599$750.82+$42.7KFCHPX
10$72,227$6,611.57$20,022$827.78+$52.2KFCHPX

FCHPX vs JNJ: Complete Analysis 2026

FCHPXStock

The fund normally invests at least 80% of its assets in investment-grade municipal securities whose interest is exempt from federal income tax (but may be subject to the federal alternative minimum tax). It potentially invests more than 25% of total assets in municipal securities that finance similar types of projects. The fund liquidates shortly after the fund's target end-date of June 30, 2023.

Full FCHPX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this FCHPX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FCHPX vs SCHDFCHPX vs JEPIFCHPX vs OFCHPX vs KOFCHPX vs MAINFCHPX vs ABBVFCHPX vs MRKFCHPX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.